Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2026-05-30 @ 7:12 PM
Study NCT ID:
NCT00028366
Status:
COMPLETED
Last Update Posted:
2021-11-01
First Post:
2001-12-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | HIV-1 | View |
| None | Drug Therapy, Combination | View |
| None | HIV Protease Inhibitors | View |
| None | Ritonavir | View |
| None | RNA, Viral | View |
| None | Reverse Transcriptase Inhibitors | View |
| None | Viral Load | View |
| None | ABT 378 | View |
| None | tenofovir disoproxil | View |
| None | VX-175 | View |
| None | Treatment Experienced | View |